Unknown

Dataset Information

0

Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.

ABSTRACT: Most solid tumors, including colorectal cancers, shed cell-free DNA (ctDNA) in the blood. ctDNA can be analyzed to generate molecular profiles which capture the heterogeneity of the disease more comprehensively then tumor tissue biopsies. This approach commonly called 'liquid biopsy' can be applied to monitor response to therapy, to assess minimal residual disease and to uncover the emergence of drug resistance. This review will discuss current and future developments of ctDNA analysis in the clinical management of colorectal cancer patients.

SUBMITTER: Siravegna G 

PROVIDER: S-EPMC5528968 | biostudies-other | 2016 Mar

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa.
| S-EPMC8448727 | biostudies-literature
Unknown Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
| S-EPMC5302475 | biostudies-literature
Unknown Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.
| S-EPMC5528781 | biostudies-literature
Unknown Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
| S-EPMC4961398 | biostudies-literature
Unknown Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
| S-EPMC6485294 | biostudies-literature
Unknown Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients.
| S-EPMC6896052 | biostudies-literature
Unknown Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer.
| S-EPMC8656875 | biostudies-literature
Unknown Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
| S-EPMC5528778 | biostudies-literature
Unknown Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
| S-EPMC5346159 | biostudies-literature
Unknown Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
| S-EPMC6894333 | biostudies-literature